相关实验视频

Updated: Jun 23, 2025

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Published on: November 11, 2016

来自iPSC的MSC中含有激活的STING的R-EVs可促进抗瘤免疫力

Linxia Qian¹, Zhonghan Zhang², Ruhua Zhang²

¹State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, Guangdong, China; School of Medicine, Shenzhen Campus of Sun Yat-sen University, Sun Yat-sen University, Shenzhen, 518107, Guangdong, China.

|June 23, 2024

概括

携带激活STING的介质干细胞衍生的细胞外囊 (R-EVs) 显示出作为无细胞免疫疗法的潜力. 这些R-EV在临床前模型中有效诱导抗瘤免疫力.

科学领域:

免疫学免疫学免疫学
癌症研究癌症研究
干细胞生物学干细胞生物学

背景情况:

激活的STING (干扰素基因刺激剂) 被分泌到RAB22A诱导的细胞外囊泡 (R-EVs) 中,并增强癌细胞中的抗瘤免疫力.
介质干细胞 (MSC) 衍生的细胞外囊泡由于其生物相容性,安全性和低免疫性而有望提供无细胞疗法.

研究的目的:

调查由含有激活STING的诱导多能干细胞 (iPSC) -MSC衍生的R-EV是否可用于新型抗瘤免疫疗法.
评估MSC衍生的R-EVs作为抗癌无细胞策略的潜力.

主要方法:

从iPSC衍生的MSC产生R-EV.
关于R-EV的尺寸和形成机制的表征.
在R-EV中评估STING的存在和激活.
通过MSC衍生的R-EVs在THP-1单细胞中体外诱导IFNβ表达.
在体内评估小鼠的抗瘤免疫力.

主要成果:

来自iPSC的MSC成功地产生了R-EV,其大小和形成机制与癌细胞的R-EV相似.
来自MSC的R-EV含有激活的STING.
这些R-EV诱导受体单细胞中的干扰素β (IFNβ) 表达.
从MSC衍生的R-EVs在小鼠模型中证明了诱导抗瘤免疫力.

结论:

含有激活STING的MSC衍生R-EVs代表了一种可行的无细胞治疗策略,用于增强抗瘤免疫力.
这种方法为开发具有更好的安全性和有效性概况的新型癌症免疫疗法提供了有前途的途径.

关键词:

反瘤免疫力抗瘤免疫力细胞外囊泡中的细胞外囊泡.介质细胞干细胞介质细胞干细胞在RAB22A中,使用的是RAB22A.拉菲体育拉菲体育拉菲体育拉菲体育刺痛是一种刺痛.

更多相关视频

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells

Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells

Published on: October 24, 2019

相关概念视频

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.